Rabadiya, Samir <br/><br/>
Magnesium valproate ameliorates type 1 diabetes and cardiomyopathy in diabetic rats through estrogen receptors.  [electronic resource] 

 -  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie  Jan 2018 
 - 919-927 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1950-6007 
<br/><br/><label>Standard No.: </label>10.1016/j.biopha.2017.10.137  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cardiomegaly--etiology<br/>Diabetes Mellitus, Experimental--drug therapy<br/>Diabetes Mellitus, Type 1--complications<br/>Diabetic Cardiomyopathies--prevention & control<br/>Disease Progression<br/>Dyslipidemias--drug therapy<br/>Female<br/>Hyperglycemia--drug therapy<br/>Male<br/>Oxidative Stress--drug effects<br/>Rats<br/>Rats, Sprague-Dawley<br/>Receptors, Estrogen--drug effects<br/>Streptozocin<br/>Up-Regulation<br/>Valproic Acid--pharmacology